Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.40 |
| ▸ | CNR1 | P21554 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2427137 | 0.78 | KMT2A (0.34) | CNR2CNR1ALDH1A1MAPTKMT2A | |
| SCHEMBL2430891 | 0.78 | CCR2 (0.38) | CNR2KMT2A | |
| SCHEMBL5444713 | 0.75 | OPRL1 (0.38) | CNR2ALDH1A1 | |
| SCHEMBL2425249 | 0.75 | CCR1 (0.39) | CNR2CNR1ALDH1A1MAPTKMT2A | |
| SCHEMBL2425084 | 0.74 | DRD2 (0.39) | CNR2CNR1KMT2A | |
| SCHEMBL2426424 | 0.72 | HDAC4 (0.39) | CNR2 | |
| SCHEMBL4920356 | 0.71 | CNR2 (0.45) | CNR2CNR1ALDH1A1MAPTKMT2A | |
| SCHEMBL4917201 | 0.71 | CNR2 (0.45) | CNR2CNR1ALDH1A1MAPTKMT2A | |
| SCHEMBL25286794 | 0.71 | — | — | |
| SCHEMBL4874228 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070179142-A1 | Amido compounds and their use as pharmaceuticals | INCYTE CORPORATION | 2007-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179142-A1 | Amido compounds and their use as pharmaceuticals | HSD11B1, CYP11B1, HSD11B2 | CNR2 1092/4885CNR1 516/4885ALDH1A1 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.